SEC Form 4 · accession 0001104659-16-129040
SELECTA BIOSCIENCES INC · SELB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Earl Sands
Officer — Chief Medical Officer
Period of report
Jun 21, 2016
Accepted (ET)
Jun 23, 2016 · 3:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001453687
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $14.00 | Jun 21, 2016 | A | 53,999 | A | — | Jun 20, 2026 | Common Stock | 53,999 | 53,999 | D |
Explanation of responses
- F1The option will vest as to 25% of the shares on June 21, 2017. The remainder of the shares will vest in 36 equal monthly installments thereafter.